Patient Reported Outcomes In Amyloidosis Cardiomyopathy

Amyloidosis cardiomyopathy is a systemic disease with high risk of disability and death. Patient-reported outcomes (PROs) are validated tools that measure health-related quality of life (HRQoL) and provide prognostic information in patients with heart failure. However, data on HRQoL profile and prognostic value of PROs in patients with cardiac amyloidosis are limited.

Source: Journal of Cardiac Failure - September 30, 2020 Category: Cardiology Authors: Alfonso Siu, Ivan Sierra, Mingyuan Zhang, Liz Dranow, Jennifer Hong, Jill Waldron, Klasina Caballero, Tom Greene, Tibor Kovacsovics, Josef Stehlik, Jose Nativi-Nicolau Tags: 330 Source Type: research